Prot #ICI-M 1201: AbatacepT foR ImmUne checkpoint inhibitor associated Myocarditis (ATRIUM): A Phase 3, Investigator-Initiated, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Abatacept Compared to Placebo in Hosp

Project: Research project

Project Details

StatusActive
Effective start/end date12/5/2412/5/27

Funding

  • Massachusetts General Hospital (Prot #ICI-M 1201 // Prot #ICI-M 1201)
  • Bristol-Myers Squibb Company (Prot #ICI-M 1201 // Prot #ICI-M 1201)